Louisiana State Employees Retirement System Takes Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Louisiana State Employees Retirement System acquired a new stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 64,900 shares of the real estate investment trust’s stock, valued at approximately $926,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. JPMorgan Chase & Co. increased its holdings in shares of Sabra Health Care REIT by 709.0% during the third quarter. JPMorgan Chase & Co. now owns 13,504,420 shares of the real estate investment trust’s stock valued at $188,252,000 after acquiring an additional 11,835,109 shares in the last quarter. Graham Capital Management L.P. purchased a new stake in Sabra Health Care REIT in the 3rd quarter valued at $1,392,000. Northern Trust Corp raised its position in Sabra Health Care REIT by 8.6% in the 3rd quarter. Northern Trust Corp now owns 3,348,859 shares of the real estate investment trust’s stock valued at $46,683,000 after buying an additional 264,569 shares during the last quarter. QRG Capital Management Inc. purchased a new stake in Sabra Health Care REIT in the 3rd quarter valued at $787,000. Finally, Principal Financial Group Inc. raised its holdings in shares of Sabra Health Care REIT by 1.5% in the third quarter. Principal Financial Group Inc. now owns 21,003,193 shares of the real estate investment trust’s stock valued at $292,783,000 after purchasing an additional 313,517 shares during the last quarter. Institutional investors own 99.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Mizuho raised their price target on shares of Sabra Health Care REIT from $15.00 to $17.00 and gave the company a “buy” rating in a research report on Wednesday, January 3rd. Wedbush reaffirmed an “outperform” rating and set a $17.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, February 29th. Finally, Deutsche Bank Aktiengesellschaft assumed coverage on shares of Sabra Health Care REIT in a research note on Tuesday, January 30th. They issued a “buy” rating and a $21.00 price target for the company. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $15.77.

Sabra Health Care REIT Trading Down 0.4 %

NASDAQ:SBRA opened at $13.65 on Friday. The company has a fifty day moving average of $14.06 and a 200 day moving average of $14.04. Sabra Health Care REIT, Inc. has a 52 week low of $10.30 and a 52 week high of $14.91. The company has a quick ratio of 3.41, a current ratio of 3.41 and a debt-to-equity ratio of 0.86. The firm has a market capitalization of $3.16 billion, a P/E ratio of 273.00, a P/E/G ratio of 4.95 and a beta of 1.16.

Sabra Health Care REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, February 29th. Stockholders of record on Tuesday, February 13th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 8.79%. The ex-dividend date of this dividend was Monday, February 12th. Sabra Health Care REIT’s dividend payout ratio is presently 2,400.00%.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.